Real-world health-related quality of life outcomes for patients with resected stage III/IV melanoma treated with adjuvant anti-PD1 therapy

Mees Egeler; Julia Lai‐Kwon; Renaud Tissier; Itske Fraterman; Anke Kuijpers; Winan J. van Houdt; Sofie Wilgenhof; Aparna D. Rao; Shahneen Sandhu; Rebecca Lee; Hanna Eriksson; Marieke van Leeuwen; Kelly de Ligt; Alexander C.J. van Akkooi; Lonneke V. van de Poll‐Franse

doi:10.1016/j.ejca.2024.113601

Related publications

Article2021

Management of resected stage III/IV melanoma with adjuvant immunotherapy.

Rebecca Johnson, Victoria Atkinson, Prachi Bhave, Alison M. Weppler, Geoffrey Peters, Afaf Abed, Megan Lyle, Muhammad Adnan Khattak, Andrew Haydon, Matteo S. Carlino, Shahneen Sandhu, Georgina V. Long, Alexander M. Menzies

Article2025

1615P Health-related quality of life in the phase III NADINA trial: Neoadjuvant vs adjuvant checkpoint blockade in stage III melanoma

Maarten Egeler, Judith Lijnsvelt, M.W. Lucas, Victoria Atkinson, Muhammad A. Khattak, Miles C. Andrews, M. Boers-Sonderen, Geke A.P. Hospers, M.S. Carlino, Jan Willem de Groot, M. Stevense-den Boer, E. Kapiteijn, K. Suijkerbuijk, P. Rutkowski, A.M. Menzies, Shahneen Sandhu, Astrid A.M. van der Veldt, G.V. Long, C.U. Blank, Lonneke V. van de Poll‐Franse

Article2022

Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Patients With Resected Stage IIIB-D or Stage IV Melanoma (CheckMate 915)

Jeffrey S. Weber, Dirk Schadendorf, Michele Del Vecchio, James Larkin, Victoria Atkinson, Michael Schenker, Jacopo Pigozzo, Helen Gogas, Stéphane Dalle, Nicolás Meyer, Paolo A. Ascierto, Shahneen Sandhu, Thomas Eigentler, Ralf Gutzmer, Jessica C. Hassel, Caroline Robert, Matteo S. Carlino, Anna Maria Di Giacomo, Marcus O. Butler, Eva Muñoz‐Couselo, Michael P. Brown, ,

Article2023

Health-related Quality of Life in Patients with Melanoma Brain Metastases Treated with Immunotherapy

Jake Thompson, Julia Lai‐Kwon, Rachael L. Morton, Alexander Guminski, Maria Gonzalez, Victoria Atkinson, Shahneen Sandhu, Michael P. Brown, Alexander M. Menzies, Grant A. McArthur, Serigne Lo, Georgina V. Long, Iris Bartula

Article2024

Incidence and risk factors for central nervous system (CNS) metastasis (met) in patients (pts) with stage III melanoma treated with adjuvant (ADJ) anti-PD1 immunotherapy (IMT).

Michael A. Davies, Julie M. Simon, Alexander M. Menzies, Denái R. Milton, James S. Wilmott, Debora Alejandra Ledesma, Elizabeth M. Burton, Sherise D. Ferguson, Hussein A. Tawbi, Jeffrey E. Gershenwald, Carlos A. Torres‐Cabala, Isabella Claudia Glitza, Alexander J. Lazar, Robyn P.M. Saw, Andrew J. Spillane, Matteo S. Carlino, Richard A Scolyer, Georgina V. Long